Novavax, Inc. Aktie News
4,09 $
3,54 %
vorgestern
Nasdaq,
26. April, 22:13 Uhr
tracken
Novavax, Inc. Aktie News
Negativ
The Motley Fool
●
16 Tage alt
Novavax's business still centers heavily around COVID-19. This year, it expects up to $1 billion in revenue.
Neutral
Accesswire
●
17 Tage alt
NEW YORK, NY / ACCESSWIRE / April 11, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Novavax, Inc. (NASDAQ:NVAX). The settlement provides for a fund of $47,000,000 to benefit class members.
Positiv
InvestorPlace
●
19 Tage alt
The 2024 presidential election is shaping up to be just as exciting and contentious the 2020 contest. That's because it looks to be a rematch between President Biden and former President Trump.
Neutral
Accesswire
●
19 Tage alt
NEW YORK, NY / ACCESSWIRE / April 9, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Novavax, Inc. (NASDAQ: NVAX). The settlement provides for a fund of $47,000,000 to benefit class members.
Positiv
MarketBeat
●
19 Tage alt
Marketbeat's many investor tools include analysts' rankings and sentiment trackers. These tools help investors and traders gauge market sentiment, showing trends and changes, updated revisions, and new reports.
Neutral
Accesswire
●
24 Tage alt
NEW YORK, NY / ACCESSWIRE / April 4, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Novavax, Inc. (NASDAQ:NVAX). The settlement provides for a fund of $47,000,000 to benefit class members.
Neutral
Accesswire
●
26 Tage alt
NEW YORK, NY / ACCESSWIRE / April 2, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Novavax, Inc. (NASDAQ:NVAX). The settlement provides for a fund of $47,000,000 to benefit class members.
Neutral
The Motley Fool
●
26 Tage alt
Teladoc's position in the growing telemedicine industry could help it turn things around. Novavax's only approved product is going nowhere and its pipeline has too little to offer.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
